METLIFECARE RETIREMENT VILLAGES LIMITED v JAMES HARDIE NEW ZEALAND LIMITED [2022] NZHC 351

METLIFECARE RETIREMENT VILLAGES LIMITED v JAMES HARDIE NEW ZEALAND LIMITED [2022] NZHC 351

The Court applied the default rule that costs follow the event while making targeted departures based on conduct and complexity: where a party prevailed on a discrete interlocutory step it received scale costs (2B/3B); complex affidavit preparation justified awarding time band C for that step; agreed Independent...

Source-derived case information.

Citation
[2022] NZHC 351
Parties
Plaintiff: Metlifecare Retirement Villages Limited; First Defendant: James Hardie New Zealand Limited; Second Defendant: Studorp Limited; Third Defendant: James Hardie NZ Holdings Limited; Fourth Defendant: RCI Holdings Pty Limited; Fifth Defendant: James Hardie Australia Pty Limited; Sixth Defendant: James Hardie Research Pty Limited; Seventh Defendant: James Hardie Industries PLC
Court
High Court
Jurisdiction
New Zealand
Judgment Date
3 March 2022
Procedural Posture
Civil Discovery (product Liability Proceedings) / Costs Judgment on Interlocutory Discovery Applications
Outcome
Costs and disbursements apportioned between the parties as set out in the orders; no costs awarded for Independent Counsel processes, late discovery memoranda or costs-on-costs memoranda; detailed monetary awards made to each party for specified interlocutory steps.
Legal Topics
Discovery Orders, Privilege and Cogency, Independent Counsel Process, Scale and Quantum of Costs, Affidavit Costs and Time Bands, Costs Uplift for Unreasonable Conduct, Tailored Discovery, Document Retention Policies
Civil Procedure Costs Discovery Evidence Product Liability Discovery Orders Privilege and Cogency Independent Counsel Process +5 more

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Legal principles 5 Authorities cited 13 Party arguments 2 Amounts and remedies 9
Sign in to unlock

Parties

Metlifecare Retirement Villages Limited

Plaintiff

James Hardie New Zealand Limited

First Defendant

Studorp Limited

Second Defendant

James Hardie NZ Holdings Limited

Third Defendant

RCI Holdings Pty Limited

Fourth Defendant

James Hardie Australia Pty Limited

Fifth Defendant

James Hardie Research Pty Limited

Sixth Defendant

James Hardie Industries PLC

Seventh Defendant

Procedural Posture

Civil Discovery (product Liability Proceedings) / Costs Judgment on Interlocutory Discovery Applications

  1. 1 Whether costs should follow the event or be otherwise apportioned
  2. 2 Whether preparation of interlocutory affidavits attracts item 30 or an uplift to time band C
  3. 3 Whether Independent Counsel processes attract costs orders

Ratio Decidendi

The Court applied the default rule that costs follow the event while making targeted departures based on conduct and complexity: where a party prevailed on a discrete interlocutory step it received scale costs (2B/3B); complex affidavit preparation justified awarding time band C for that step; agreed Independent Counsel processes did not, by themselves, attract costs awards; and where a party unduly prolonged or complicated the process limited uplifts or reductions were applied. The Court quantified and apportioned costs across multiple discovery hearings accordingly and made specific monetary awards and percentage adjustments set out in the orders.

Court Disposition

Costs and disbursements apportioned between the parties as set out in the orders; no costs awarded for Independent Counsel processes, late discovery memoranda or costs-on-costs memoranda; detailed monetary awards made to each party for specified interlocutory steps.

Orders

  • James Hardie New Zealand Limited awarded 3B costs of NZD 12796.25 and disbursements in respect of Metlifecare's 6 December 2019 application (Judgment No 5).
  • Metlifecare Retirement Villages Limited awarded 3B costs of NZD 18086.00 and disbursements in respect of its updating memorandum dated 11 March 2020 and Judgment No 7 dated 3 April 2020.